Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
International Journal of Pharmaceutics|December 29, 2004
A practical note on the use of cytotoxicity assaysJörg Weyermann, Dirk Lochmann, Andreas ZimmerJournal of Controlled Release : Official Journal of the Controlled Release Society|November 30, 2004
Comparison of antisense oligonucleotide drug delivery systemsJörg Weyermann, Dirk Lochmann, Andreas ZimmerCurrent Pharmaceutical Biotechnology|February 25, 2005
Recombinant virus like particles as drug delivery systemChristiane Georgens, Jörg Weyermann, Andreas ZimmerEuropean Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2005
Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effectJörg Weyermann, Dirk Lochmann, Christiane Georgens, et al.International Journal of Pharmaceutics|September 15, 2004
New protamine quantification method in microtiter plates using o-phthaldialdehyde/N-acetyl-L-cysteine reagentDirk Lochmann, Sylvia Stadlhofer, Jörg Weyermann, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2005
Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: physicochemical characterizationDirk Lochmann, Jörg Weyermann, Christiane Georgens, et al.Oligonucleotides|April 24, 2004
Rapid screening method for antisense oligonucleotides against human growth factor receptor p185(erbB-2)Anke Rohmann, Dirk Lochmann, Jörg Weyermann, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 23, 2004
Physicochemical characterisation of cationic polybutylcyanoacrylate-nanoparticles by fluorescence correlation spectroscopyJörg Weyermann, Dirk Lochmann, Christiane Georgens, et al.Oligonucleotides|December 13, 2006
Immunostimulatory properties of CpG-oligonucleotides are enhanced by the use of protamine nanoparticlesMiren Kerkmann, Dirk Lochmann, Jörg Weyermann, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 9, 2005
Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reductionGottfried Mayer, Vitali Vogel, Jörg Weyermann, et al.Pageof 2